Abstract
This editorial is focused on the double controversial action of erythropoietin, acting as anticancer agent and as a promoting cancer agent.
Original language | English |
---|---|
Pages (from-to) | 1-4 |
Number of pages | 4 |
Journal | Leukemia Research |
Volume | 33 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 2009 |
Keywords
- Erythropoietin
- Erythropoietin receptor
- Erythropoietin-stimulating agents
- Tumor progression
ASJC Scopus subject areas
- Cancer Research
- Hematology
- Oncology